FDA Rejects Regeneron's Eylea HD The US Food and Drug Administration (FDA) has rejected a prefilled syringe version of Regeneron's Eylea HD (aflibercept) due to manufacturing issues.
Allied Nations Invest in Critical Minerals Supply Chains Western governments have committed $8.5 billion to accelerate mining and processi…
In the Maldives, Luxury Takes Many Shapes For travelers to this dreamy archipelago, helping keep its waters and beaches pristine is a vaca…
PSG Seek to Extend Lead in Ligue 1 with Win Against Lorient Paris St Germain had a successful weekend, winning 3-0 away at Brest and retur…
European Parliament Considers Banning Russian Media The European Parliament is weighing a ban on Russian media outlets from its networks, …